Nev. Admin. Code § 639.Sec. 3.4

Current through June 11, 2024
Section 639.Sec. 3.4 - NEW
1. A pharmacist may prescribe, dispense and administer drugs approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus pursuant to section 1 of Senate Bill No. 325, chapter 492, Statutes of Nevada 2021, at page 3201 (NRS 639.28085) , if the pharmacist has completed a course of training concerning the prescribing, dispensing and administering of such drugs. The course must be:
(a) Approved by the Accreditation Council for Pharmacy Education, or its successor organization; or
(b) Offered by a college of pharmacy or department of pharmacy at a university accredited by the Accreditation Council for Pharmacy Education, or its successor organization.
2. A pharmacist who prescribes, dispenses or administers drugs approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus pursuant to section 1 of Senate Bill No. 325, chapter 492, Statutes of Nevada 2021, at page 3201 (NRS 639.28085) , shall maintain and make readily available proof of completion of a course completed pursuant to subsection 1 while the pharmacist prescribes, dispenses or administers such drugs, as applicable, and for at least 2 years following that prescribing, dispensing or administering.
3. A pharmacist who prescribes, dispenses or administers drugs approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus pursuant to section 1 of Senate Bill No. 325, chapter 492, Statutes of Nevada 2021, at page 3201 (NRS 639.28085) , shall maintain professional liability insurance coverage of at least $1,000,000.

Nev. Admin. Code § 639.Sec. 3.4

Added to NAC by Bd. of Pharmacy by R039-21A, eff. 4/11/2022
NRS 639.070, section 1 of Senate Bill No. 325, chapter 492, Statutes of Nevada 2021, at page 3201 (NRS 639.28085)